Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Chem Res Toxicol. 2005 Oct;18(10):1537-44. doi: 10.1021/tx0501637.

Abstract

Secondary and tertiary alicyclic amines are widely found in pharmaceuticals and environmental compounds. The formation of iminium ions as reactive intermediates in the metabolic activation of alicyclic amines has previously been investigated in radiometric assays where radiolabeled cyanide is typically employed. In this paper, we report a relatively high throughput LC-MS/MS method for the detection of the nonradiolabeled cyanide adduct formed in rat or human liver microsomal incubations via constant neutral loss scan followed by structural characterization using product ion scan on a triple quadrupole mass spectrometer. A total of 14 alicyclic amine compounds were investigated with the cyanide trapping LC-MS/MS screen and also with the glutathione (GSH) trapping screen, a well-established and commonly employed technique for reactive metabolite screening. Our results are found to be in general agreement with the previous metabolism reports for these compounds, demonstrating the effectiveness, speed, and simplicity of the cyanide trapping LC-MS/MS method to study the iminium ion intermediates from alicyclic amines and its complementarities to GSH trapping method for reactive metabolite screenings.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amines / chemistry
  • Amines / metabolism*
  • Animals
  • Chromatography, Liquid / methods
  • Glutathione
  • Humans
  • Imines / analysis*
  • Mass Spectrometry / methods
  • Microsomes, Liver / metabolism*
  • Nicotine / metabolism
  • Piperazines
  • Potassium Cyanide
  • Prochlorperazine / metabolism*
  • Rats
  • Triazoles / metabolism*

Substances

  • Amines
  • Imines
  • Piperazines
  • Triazoles
  • nefazodone
  • Nicotine
  • Glutathione
  • Potassium Cyanide
  • Prochlorperazine